Help! Please Register

  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: The Fungi > Descriptions >


Aspergillus terreus
Thom, 1918

Macroscopic morphology

Colonies on potato dextrose agar at 25°C are beige to buff to cinnamon. Reverse is yellow and yellow soluble pigments are frequently present. Moderate to rapid growth rate. Colonies become finely granular with conidial production.

Microscopic morphology

Hyphae are septate and hyaline. Conidial heads are biseriate (containing metula that support phialides) and columnar (conidia form in long columns from the upper portion of the vesicle). Conidiophores are smooth-walled and hyaline, 70 to 300µm long, terminating in mostly globose vesicles. Conidia are small (2-2.5 µm), globose, and smooth. Globose, sessile, hyaline accessory conidia (2-6 µm) frequently produced on submerged hyphae.[531, 2202].

Special notes

This species is noteworthy for its refractoriness to amphotericin B therapy [2202, 2203], [1440, 2367] [2152], [891]. Isolates that are initially white and producing only accessory conidia may be mistaken for Histoplasma capsulatum [2202].

FTL* in vitro susceptibility data

AMB CAS ITRA VORI POSA TERB 5FC MICA ANID
0.5 µg/ml=1 0.03 µg/ml=14 0.03 µg/ml=2 0.125 µg/ml=2 0.03 µg/ml=5 0.004 µg/ml=2 >64 µg/ml=15 0.03 µg/ml=6 0.03 µg/ml=1
1.0 µg/ml=6 0.06 µg/ml=16 0.06 µg/ml=9 0.25 µg/ml=22 0.06 µg/ml=13 0.015 µg/ml=2      
2.0 µg/ml=40 0.125 µg/ml=37 0.125 µg/ml=36 0.5 µg/ml=60 0.125 µg/ml=9 0.03 µg/ml=5      
4.0 µg/ml=46 0.25 µg/ml=20 0.25 µg/ml=20 1.0 µg/ml=11   0.06 µg/ml=1      
8.0 µg/ml=11 1.0 µg/ml=1 0.5 µg/ml=2     0.125 µg/ml=1      
16 µg/ml=1 2.0 µg/ml=2 1.0 µg/ml=3            
  4.0 µg/ml=4              


Drug/N AMB/105 CAS/94 ITRA/72 VORI/95 POSA/27
MIC Range 0.5-8.0 0.03-4.0 0.03-1.0 0.25-1.0 0.03-0.125
MIC50 4.0 0.125 0.125 0.5 0.06
MIC90 4.0 0.25 0.25 1.0 0.125
* Fungus Testing Laboratory unpublished data (NCCLS M38-A)


Search

PubMed

Nucleotides

GenBank



Delicate, biseriate fruiting head
Delicate, biseriate fruiting head



References

531. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed, vol. 1. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.

891. Graybill, J. R., S. Hernandez, R. Bocanegra, and L. K. Najvar. 2004. Antifungal therapy of murine Aspergillus terreus infection. Antimicrob. Agents Chemother. 48:3715-3719.

1440. Marr, K. A., T. Patterson, and D. Denning. 2002. Aspergillosis - Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin N Amer. 16:875-894,VI.

2152. Steinbach, W. J., D. K. Benjamin, Jr., D. P. Kontoyiannis, J. R. Perfect, I. Lutsar, K. A. Marr, M. S. Lionakis, H. A. Torres, H. Jafri, and T. J. Walsh. 2004. Infections due to Aspergillus terreus: A multicenter retrospective analysis of 83 cases. Clin Infect Dis. 39:192-198.

2202. Sutton, D. A., A. W. Fothergill, and M. G. Rinaldi (ed.). 1998. Guide to Clinically Significant Fungi, 1st ed. Williams & Wilkins, Baltimore.

2203. Sutton, D. A., S. E. Sanche, S. G. Revankar, A. W. Fothergill, and M. G. Rinaldi. 1999. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol. 37:2343-2345.

2367. Walsh, T. J., V. Petraitis, R. Petraitiene, A. Field-Ridley, D. Sutton, M. Ghannoum, T. Sein, R. Schaufele, J. Peter, J. Bacher, H. Casler, D. Armstrong, A. Espinel-Ingroff, M. G. Rinaldi, and C. A. Lyman. 2003. Experimental pulmonary aspergillosis due to Aspergillus terreus: Pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infec Dis. 188:305-319.



  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif